Ranolazine a Potential New Therapeutic Application

NCT02687269 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inability to produce placebo tablets similar to the drug tested

Conditions

Myocardial Stunning

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS